back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-02 10:21 Tx date 2024-04-01 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,253 vol |
28,998 | |
| Filed 2024-03-29 16:44 Tx date 2024-03-25 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+5,000 vol $4.00 each |
341,702 | |
| Filed 2024-03-01 19:26 Tx date 2024-03-01 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,765 vol |
25,745 | |
| Filed 2024-02-22 09:24 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-17,142 vol |
2,858 | |
| Filed 2024-02-22 09:23 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-171 vol |
29 | |
| Filed 2024-02-05 13:00 Tx date 2024-02-01 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,978 vol |
22,980 | |
| Filed 2024-01-26 11:47 Tx date 2023-12-23 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
55 - Expiration of warrants
|
-303 vol |
0 | |
| Filed 2024-01-26 11:47 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
37 - Stock split or consolidation
|
-1,816 vol |
303 | |
| Filed 2024-01-26 11:46 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class A Purchase Warrants
37 - Stock split or consolidation
|
-1,816 vol |
303 | |
| Filed 2024-01-26 11:46 Tx date 2023-07-08 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class A Purchase Warrants
55 - Expiration of warrants
|
-1,371 vol |
2,119 | |
| Filed 2024-01-26 11:45 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-79,885 vol |
13,315 | |
| Filed 2024-01-26 11:44 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-415,559 vol |
69,264 | |
| Filed 2024-01-26 11:44 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-26,126 vol |
4,354 | |
| Filed 2024-01-19 16:20 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Olson, Charles
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-17,142 vol |
2,858 | |
| Filed 2024-01-15 14:07 Tx date 2023-07-08 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class A Purchase Warrants
55 - Expiration of warrants
|
-1,827 vol |
0 | |
| Filed 2024-01-15 14:07 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-70,616 vol |
11,773 | |
| Filed 2024-01-15 14:06 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-3,132 vol |
522 | |
| Filed 2024-01-13 11:20 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-14,914 vol |
2,486 | |
| Filed 2024-01-13 11:20 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-64,285 vol |
10,715 | |
| Filed 2024-01-13 11:18 Tx date 2023-12-23 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Indirect Ownership)
|
Warrants Class B Purchase Warrants
55 - Expiration of warrants
|
-16,305 vol |
0 | |
| Filed 2024-01-13 11:17 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Indirect Ownership)
|
Warrants Class B Purchase Warrants
37 - Stock split or consolidation
|
-97,826 vol |
16,305 | |
| Filed 2024-01-13 11:17 Tx date 2023-12-23 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class B Purchase Warrants
55 - Expiration of warrants
|
-16,305 vol |
0 | |
| Filed 2024-01-13 11:17 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class B Purchase Warrants
37 - Stock split or consolidation
|
-97,826 vol |
16,305 | |
| Filed 2024-01-13 11:16 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Indirect Ownership)
|
Warrants Class A Purchase Warrants
37 - Stock split or consolidation
|
-97,826 vol |
16,305 | |
| Filed 2024-01-13 11:16 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class A Purchase Warrants
37 - Stock split or consolidation
|
-104,768 vol |
16,305 | |
| Filed 2024-01-13 11:15 Tx date 2024-01-08 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,908 vol |
20,002 | |
| Filed 2024-01-13 11:15 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-82,206 vol |
17,094 | |
| Filed 2024-01-13 11:14 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-341,235 vol |
56,875 | |
| Filed 2024-01-13 11:13 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-195,653 vol |
32,609 | |
| Filed 2024-01-13 11:13 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The Digestive Health Clinic Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-192,081 vol |
32,013 | |
| Filed 2024-01-13 11:12 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-2,020,212 vol |
336,702 | |
| Filed 2024-01-13 11:12 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1968160 Ontario Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-318,623 vol |
53,104 | |
| Filed 2024-01-13 11:12 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-509,839 vol |
84,973 | |
| Filed 2024-01-12 20:16 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-70,616 vol |
11,773 | |
| Filed 2024-01-12 20:16 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-12,316 vol |
2,053 | |
| Filed 2023-08-04 18:10 Tx date 2023-08-04 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+93,200 vol |
93,200 | |
| Filed 2023-08-04 18:09 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-04 17:40 Tx date 2023-08-04 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+99,300 vol |
99,300 | |
| Filed 2023-08-04 17:39 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-04 17:37 Tx date 2023-08-04 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+17,400 vol |
17,400 | |
| Filed 2023-08-04 17:34 Tx date 2023-07-15 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-21 18:26 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
| Filed 2023-07-21 18:25 Tx date 2023-05-23 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-21 18:22 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Marshall, Patrick Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
| Filed 2023-07-21 18:21 Tx date 2023-05-23 |
$EDSA
Edesa Biotech, Inc. |
Marshall, Patrick Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-21 18:20 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Olson, Charles
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
| Filed 2023-07-21 18:18 Tx date 2023-05-23 |
$EDSA
Edesa Biotech, Inc. |
Olson, Charles
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-21 18:14 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
82,389 | |
| Filed 2023-07-21 18:11 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+75,000 vol |
75,000 | |
| Filed 2023-07-21 18:09 Tx date 2023-07-15 |
$EDSA
Edesa Biotech, Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-21 18:08 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
82,389 | |
| Filed 2023-07-21 18:05 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+80,000 vol |
484,823 | |
| Filed 2023-07-21 18:01 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
83,341 | |
| Filed 2023-07-21 17:58 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+120,000 vol |
398,110 | |
| Filed 2023-05-24 20:01 Tx date 2023-05-23 |
$EDSA
Edesa Biotech, Inc. |
Marshall, Patrick Jeffrey
4 - Director of Issuer
Holder: Quidnet Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,254 | ||
| Filed 2023-05-24 20:00 Tx date 2023-05-23 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
200 | ||
| Filed 2023-01-12 17:30 Tx date 2023-01-10 |
$EDSA
Edesa Biotech, Inc. |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-33,973.167
-12,895 vol $2.63 each |
150,275 | |
| Filed 2023-01-12 17:29 Tx date 2023-01-10 |
$EDSA
Edesa Biotech, Inc. |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-367,394.97
-139,450 vol $2.63 each |
1,625,133 | |
| Filed 2023-01-12 17:29 Tx date 2023-01-09 |
$EDSA
Edesa Biotech, Inc. |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,701.2364
-12,284 vol $2.66 each |
163,170 | |
| Filed 2023-01-12 17:28 Tx date 2023-01-09 |
$EDSA
Edesa Biotech, Inc. |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-353,646.6745
-132,845 vol $2.66 each |
1,764,583 | |
| Filed 2022-12-22 08:48 Tx date 2022-12-22 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
52 - Expiration of options
|
-238 vol |
263,270 | |
| Filed 2022-11-07 16:43 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Control or Direction)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+114,131 vol |
114,131 | |
| Filed 2022-11-07 16:42 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Control or Direction)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-07 16:42 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+114,131 vol |
114,131 | |
| Filed 2022-11-07 16:38 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Control or Direction)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+114,131 vol |
114,131 | |
| Filed 2022-11-07 16:37 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Control or Direction)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-07 16:37 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+114,131 vol |
121,073 | |
| Filed 2022-11-07 16:35 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$256,794
+228,262 vol $1.13 each |
228,262 | |
| Filed 2022-11-07 16:34 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-07 16:33 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$256,794
+228,262 vol $1.13 each |
2,356,914 | |
| Filed 2022-11-07 16:29 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+4,444 vol |
4,444 | |
| Filed 2022-11-07 16:27 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+4,444 vol |
5,358 | |
| Filed 2022-11-07 16:26 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$9,999
+8,888 vol $1.13 each |
10,715 | |
| Filed 2022-11-07 16:19 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+2,119 vol |
2,119 | |
| Filed 2022-11-07 16:18 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+2,119 vol |
3,490 | |
| Filed 2022-11-07 16:17 Tx date 2022-11-02 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,768
+4,239 vol $1.13 each |
30,480 | |
| Filed 2022-07-05 21:21 Tx date 2022-06-30 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,250
+6,167 vol $1.66 each |
594,812 | |
| Filed 2022-07-05 21:20 Tx date 2022-06-30 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,068
+8,188 vol $1.60 each |
588,645 | |
| Filed 2022-07-05 21:19 Tx date 2022-06-30 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,779
+5,000 vol $1.56 each |
580,457 | |
| Filed 2022-07-05 21:19 Tx date 2022-06-30 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$980.40
+645 vol $1.52 each |
575,457 | |
| Filed 2022-06-30 12:23 Tx date 2022-06-29 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,482
+3,000 vol $1.49 each |
26,241 | |
| Filed 2022-06-24 17:08 Tx date 2022-06-16 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,816
+3,000 vol $1.61 each |
23,241 | |
| Filed 2022-05-27 12:14 Tx date 2022-05-27 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,599
+5,000 vol $1.92 each |
574,812 | |
| Filed 2022-05-26 15:36 Tx date 2022-05-24 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,599
+2,000 vol $1.80 each |
569,812 | |
| Filed 2022-05-26 15:03 Tx date 2022-05-25 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,090
+3,500 vol $1.74 each |
20,241 | |
| Filed 2022-04-01 16:08 Tx date 2022-03-31 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,971
+2,000 vol $2.99 each |
567,812 | |
| Filed 2022-03-31 14:43 Tx date 2022-03-30 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,098
+2,000 vol $3.05 each |
565,812 | |
| Filed 2022-03-31 13:19 Tx date 2022-03-29 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,033
+2,000 vol $3.02 each |
563,812 | |
| Filed 2022-03-30 19:27 Tx date 2022-03-28 |
$EDSA
Edesa Biotech, Inc. |
Chao, Jennifer M.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+30,000 vol |
30,000 | |
| Filed 2022-03-30 19:26 Tx date 2022-03-28 |
$EDSA
Edesa Biotech, Inc. |
Chao, Jennifer M.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-21 11:09 Tx date 2022-03-18 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,699
+2,000 vol $3.85 each |
561,812 | |
| Filed 2022-03-18 13:22 Tx date 2022-03-17 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,232
+1,603 vol $3.26 each |
559,812 | |
| Filed 2022-03-18 13:21 Tx date 2022-03-17 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,290
+397 vol $3.25 each |
558,209 | |
| Filed 2022-03-16 14:35 Tx date 2022-03-15 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,598
+2,000 vol $2.80 each |
557,812 | |
| Filed 2022-03-16 14:31 Tx date 2022-03-14 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,486
+1,250 vol $2.79 each |
16,741 | |
| Filed 2022-03-14 15:53 Tx date 2022-03-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,294
+5,000 vol $3.06 each |
555,812 | |
| Filed 2022-03-14 15:52 Tx date 2022-03-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,357
+2,000 vol $3.18 each |
550,812 | |
| Filed 2022-03-14 13:16 Tx date 2022-03-10 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,222
+1,000 vol $3.22 each |
15,491 | |
| Filed 2022-03-11 12:25 Tx date 2022-03-09 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,569
+1,500 vol $3.05 each |
548,812 | |
| Filed 2022-03-10 12:00 Tx date 2022-03-08 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,621
+1,250 vol $2.90 each |
14,491 | |
| Filed 2022-03-05 23:44 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
94,788 | |
| Filed 2022-03-05 23:39 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
62,389 | |
| Filed 2022-03-05 23:36 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+49,000 vol |
278,110 | |
| Filed 2022-03-05 23:32 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
62,389 | |
| Filed 2022-03-05 23:28 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
62,389 | |
| Filed 2022-03-05 23:18 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
63,341 | |
| Filed 2022-03-05 23:13 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+43,500 vol |
404,823 | |
| Filed 2022-03-05 23:04 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
||
| Filed 2022-03-05 11:37 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
||
| Filed 2022-03-05 11:31 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
||
| Filed 2022-03-05 00:41 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+49,000 vol |
||
| Filed 2022-03-05 00:37 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
||
| Filed 2022-03-05 00:31 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
||
| Filed 2022-03-05 22:54 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+43,500 vol |
263,508 | |
| Filed 2022-03-05 11:37 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
94,788 | |
| Filed 2022-03-05 11:31 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
62,389 | |
| Filed 2022-03-05 00:41 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+49,000 vol |
278,110 | |
| Filed 2022-03-05 00:37 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
62,389 | |
| Filed 2022-03-05 00:31 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
62,389 | |
| Filed 2021-11-15 16:24 Tx date 2021-11-12 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
52 - Expiration of options
|
$-136,617.60
-214 vol $638.40 each |
220,008 | |
| Filed 2021-04-27 21:29 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
51,389 | |
| Filed 2021-04-27 16:33 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
83,788 | |
| Filed 2021-04-27 16:30 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
51,389 | |
| Filed 2021-04-27 16:26 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
51,389 | |
| Filed 2021-04-27 16:23 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
52,341 | |
| Filed 2021-04-27 16:20 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+120,000 vol |
229,110 | |
| Filed 2021-04-27 16:17 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
51,389 | |
| Filed 2021-04-27 16:14 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+80,000 vol |
220,222 | |
| Filed 2021-04-27 16:09 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+80,000 vol |
361,323 | |
| Filed 2021-03-29 13:17 Tx date 2021-03-29 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,460
+2,000 vol $5.23 each |
547,312 | |
| Filed 2021-03-26 16:38 Tx date 2021-03-25 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,165
+3,500 vol $5.19 each |
13,241 | |
| Filed 2021-03-26 16:36 Tx date 2021-03-24 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,860
+4,500 vol $5.08 each |
9,741 | |
| Filed 2021-03-26 16:01 Tx date 2021-03-25 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,750
+3,000 vol $5.25 each |
545,312 | |
| Filed 2021-03-26 16:00 Tx date 2021-03-24 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,800
+5,000 vol $5.16 each |
542,312 | |
| Filed 2021-02-19 16:12 Tx date 2021-02-18 |
$EDSA
Edesa Biotech, Inc. |
Oakes, Frank R.
4 - Director of Issuer
Holder: Frank and Dorothy Oakes Fam TR (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,245.75
-1,827 vol $7.25 each |
0 | |
| Filed 2021-02-19 16:11 Tx date 2021-02-18 |
$EDSA
Edesa Biotech, Inc. |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-44,696.25
-6,165 vol $7.25 each |
0 | |
| Filed 2020-11-12 17:23 Tx date 2020-11-06 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$3,656
+914 vol $4.00 each |
5,241 | |
| Filed 2020-11-12 17:22 Tx date 2020-11-06 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
54 - Exercise of warrants
|
-914 vol |
0 | |
| Filed 2020-11-11 14:25 Tx date 2020-11-06 |
$EDSA
Edesa Biotech, Inc. |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$4,872
+1,218 vol $4.00 each |
3,654 | |
| Filed 2020-11-11 14:24 Tx date 2020-11-06 |
$EDSA
Edesa Biotech, Inc. |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
54 - Exercise of warrants
|
-1,218 vol |
0 | |
| Filed 2020-11-11 14:21 Tx date 2020-11-09 |
$EDSA
Edesa Biotech, Inc. |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$17,048
+4,262 vol $4.00 each |
12,786 | |
| Filed 2020-11-11 14:20 Tx date 2020-11-09 |
$EDSA
Edesa Biotech, Inc. |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
54 - Exercise of warrants
|
-4,262 vol |
0 | |
| Filed 2020-11-11 14:15 Tx date 2020-11-06 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$2,436
+609 vol $4.00 each |
1,827 | |
| Filed 2020-11-11 14:14 Tx date 2020-11-06 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class B Purchase Warrants
54 - Exercise of warrants
|
-609 vol |
0 | |
| Filed 2020-11-09 22:21 Tx date 2020-11-05 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$4,872
+1,218 vol $4.00 each |
3,654 | |
| Filed 2020-11-09 22:19 Tx date 2020-11-05 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
54 - Exercise of warrants
|
-1,218 vol |
0 | |
| Filed 2020-11-09 16:16 Tx date 2020-11-05 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$18,512
+4,628 vol $4.00 each |
2,128,652 | |
| Filed 2020-11-09 16:15 Tx date 2020-11-05 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class B Purchase Warrants
54 - Exercise of warrants
|
-4,628 vol |
0 | |
| Filed 2020-11-05 18:34 Tx date 2020-11-02 |
$EDSA
Edesa Biotech, Inc. |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$23,808
+5,952 vol $4.00 each |
175,454 | |
| Filed 2020-11-05 18:33 Tx date 2020-11-02 |
$EDSA
Edesa Biotech, Inc. |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
54 - Exercise of warrants
|
-5,952 vol |
0 | |
| Filed 2020-11-05 18:32 Tx date 2020-11-02 |
$EDSA
Edesa Biotech, Inc. |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$257,448
+64,362 vol $4.00 each |
1,897,428 | |
| Filed 2020-11-05 18:31 Tx date 2020-11-02 |
$EDSA
Edesa Biotech, Inc. |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
54 - Exercise of warrants
|
-64,362 vol |
0 | |
| Filed 2020-11-04 16:14 Tx date 2020-10-06 |
$EDSA
Edesa Biotech, Inc. |
Oakes, Frank R.
4 - Director of Issuer
Holder: Frank and Dorothy Oakes Fam TR (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$2,436
+609 vol $4.00 each |
1,827 | |
| Filed 2020-11-04 16:13 Tx date 2020-10-06 |
$EDSA
Edesa Biotech, Inc. |
Oakes, Frank R.
4 - Director of Issuer
Holder: Frank and Dorothy Oakes Fam TR (Indirect Ownership)
|
Warrants Class B Purchase Warrants
54 - Exercise of warrants
|
-609 vol |
0 | |
| Filed 2020-11-03 16:41 Tx date 2020-11-01 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
52 - Expiration of options
|
-238 vol |
140,222 | |
| Filed 2020-10-16 20:48 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
31,389 | |
| Filed 2020-10-16 10:28 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$148,800
+20,000 vol $7.44 each |
31,389 | |
| Filed 2020-10-16 10:24 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$148,800
+20,000 vol $7.44 each |
63,788 | |
| Filed 2020-10-15 17:13 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$148,800
+20,000 vol $7.44 each |
32,341 | |
| Filed 2020-10-15 16:15 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$148,800
+20,000 vol $7.44 each |
31,389 | |
| Filed 2020-10-15 16:12 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$372,000
+50,000 vol $7.44 each |
281,323 | |
| Filed 2020-10-15 14:46 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$148,800
+20,000 vol $7.44 each |
31,389 | |
| Filed 2020-10-15 14:05 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$372,000
+50,000 vol $7.44 each |
140,460 | |
| Filed 2020-10-15 13:02 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$446,400
+60,000 vol $7.44 each |
109,110 | |
| Filed 2020-10-15 12:57 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-231,759 vol |
46,352 | |
| Filed 2020-10-15 12:54 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
278,111 | ||
| Filed 2019-06-20 12:31 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-346,430 vol |
||
| Filed 2019-06-20 12:30 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-22 16:21 Tx date 2020-09-17 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1968160 Ontario Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+371,727 vol |
371,727 | |
| Filed 2020-09-22 16:20 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1968160 Ontario Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-29 19:44 Tx date 2020-05-27 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000
+1,000 vol $3.00 each |
4,327 | |
| Filed 2020-05-29 19:42 Tx date 2020-05-27 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,498
+1,500 vol $3.00 each |
3,327 | |
| Filed 2020-05-28 14:19 Tx date 2020-05-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,939
+3,000 vol $2.98 each |
2,124,024 | |
| Filed 2020-05-14 12:05 Tx date 2020-05-14 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
52 - Expiration of options
|
-214 vol |
90,460 | |
| Filed 2020-03-22 21:47 Tx date 2020-03-17 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,828
+1,000 vol $1.83 each |
2,120,024 | |
| Filed 2020-03-22 21:45 Tx date 2020-03-17 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,897
+1,000 vol $1.90 each |
2,121,024 | |
| Filed 2020-03-22 21:44 Tx date 2020-03-17 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,897
+1,000 vol $1.90 each |
||
| Filed 2020-03-22 21:43 Tx date 2020-03-17 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,897
+1,000 vol $1.90 each |
2,119,024 | |
| Filed 2020-03-22 21:43 Tx date 2020-03-17 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,859
+1,000 vol $1.86 each |
2,118,024 | |
| Filed 2020-03-22 21:42 Tx date 2020-03-17 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,889
+1,000 vol $1.89 each |
2,117,024 | |
| Filed 2020-02-17 22:27 Tx date 2020-02-12 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,389 vol |
12,341 | |
| Filed 2020-02-17 22:24 Tx date 2020-02-12 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,389 vol |
43,788 | |
| Filed 2020-02-17 18:34 Tx date 2020-02-12 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+88,699 vol |
90,674 | |
| Filed 2020-02-17 18:33 Tx date 2019-12-19 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
52 - Expiration of options
|
-119 vol |
1,975 | |
| Filed 2020-02-17 18:31 Tx date 2019-06-18 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
52 - Expiration of options
|
-214 vol |
2,094 | |
| Filed 2020-02-17 18:28 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-11,551 vol |
2,308 | |
| Filed 2020-02-17 18:25 Tx date 2020-02-12 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+68,988 vol |
231,323 | |
| Filed 2020-02-17 18:21 Tx date 2020-02-12 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,389 vol |
11,389 | |
| Filed 2020-02-17 18:18 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-25 09:55 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-11,549 vol |
||
| Filed 2019-06-10 20:26 Tx date 2019-06-10 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-11,549 vol |
||
| Filed 2020-02-15 18:06 Tx date 2020-02-12 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,389 vol |
11,389 | |
| Filed 2020-02-15 18:01 Tx date 2020-02-12 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,389 vol |
11,389 | |
| Filed 2020-02-14 21:20 Tx date 2020-02-12 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,389 vol |
11,389 | |
| Filed 2020-02-14 21:15 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-14 09:43 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,218 vol |
1,218 | |
| Filed 2020-01-14 09:42 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+609 vol |
609 | |
| Filed 2020-01-14 09:41 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+914 vol |
914 | |
| Filed 2020-01-14 09:39 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+914 vol |
914 | |
| Filed 2020-01-14 09:38 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$7,502
+1,827 vol $4.11 each |
1,827 | |
| Filed 2020-01-14 09:32 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,002
+2,436 vol $4.11 each |
2,436 | |
| Filed 2020-01-13 23:49 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+914 vol |
||
| Filed 2020-01-13 23:49 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+914 vol |
914 | |
| Filed 2020-01-13 23:48 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:47 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,371 vol |
1,371 | |
| Filed 2020-01-13 23:46 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:46 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$7,502
+1,827 vol $4.11 each |
1,827 | |
| Filed 2020-01-13 23:46 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$7,502
+1,827 vol $4.11 each |
||
| Filed 2020-01-13 23:45 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:43 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+4,628 vol |
4,628 | |
| Filed 2020-01-13 23:42 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:41 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+6,942 vol |
6,942 | |
| Filed 2020-01-13 23:40 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:40 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$38,003
+9,255 vol $4.11 each |
2,116,024 | |
| Filed 2020-01-13 23:36 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,218 vol |
1,218 | |
| Filed 2020-01-13 23:36 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,218 vol |
||
| Filed 2020-01-13 23:35 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:34 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,827 vol |
1,827 | |
| Filed 2020-01-13 23:33 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:33 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,002
+2,436 vol $4.11 each |
2,436 | |
| Filed 2020-01-13 23:32 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:29 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,218 vol |
1,218 | |
| Filed 2020-01-13 23:28 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:28 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,827 vol |
1,827 | |
| Filed 2020-01-13 23:26 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:26 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,002
+2,436 vol $4.11 each |
2,436 | |
| Filed 2020-01-13 23:26 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,002
+2,436 vol $4.11 each |
||
| Filed 2020-01-13 23:25 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:23 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+4,262 vol |
4,262 | |
| Filed 2020-01-13 23:22 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:22 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+6,393 vol |
6,393 | |
| Filed 2020-01-13 23:20 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:19 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$35,002
+8,524 vol $4.11 each |
8,524 | |
| Filed 2020-01-13 23:12 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Holder: Frank and Dorothy Oakes Fam TR (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+609 vol |
609 | |
| Filed 2020-01-13 23:11 Tx date 2010-04-09 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Holder: Frank and Dorothy Oakes Fam TR (Indirect Ownership)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:11 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Holder: Frank and Dorothy Oakes Fam TR (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+914 vol |
914 | |
| Filed 2020-01-13 23:09 Tx date 2010-04-09 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Holder: Frank and Dorothy Oakes Fam TR (Indirect Ownership)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:09 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Holder: Frank and Dorothy Oakes Fam TR (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,001
+1,218 vol $4.11 each |
1,218 | |
| Filed 2020-01-13 23:07 Tx date 2010-04-09 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Holder: Frank and Dorothy Oakes Fam TR (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 23:01 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+5,952 vol |
5,952 | |
| Filed 2020-01-13 23:00 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:23 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+609 vol |
||
| Filed 2020-01-13 22:21 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+914 vol |
||
| Filed 2020-01-13 22:59 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+64,362 vol |
64,362 | |
| Filed 2020-01-13 22:58 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:57 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+96,542 vol |
96,542 | |
| Filed 2020-01-13 22:56 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:55 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+8,928 vol |
8,928 | |
| Filed 2020-01-13 22:48 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+96,542 vol |
||
| Filed 2020-01-13 22:47 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:46 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$38,089
+11,903 vol $3.20 each |
169,502 | |
| Filed 2020-01-13 22:45 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$411,910
+128,722 vol $3.20 each |
1,833,066 | |
| Filed 2020-01-13 22:40 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+5,952 vol |
5,952 | |
| Filed 2020-01-13 22:38 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:38 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+8,928 vol |
8,928 | |
| Filed 2020-01-13 22:35 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Indirect Ownership)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:35 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$38,089
+11,903 vol $3.20 each |
169,502 | |
| Filed 2020-01-13 22:33 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+64,362 vol |
64,362 | |
| Filed 2020-01-13 22:31 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:31 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+96,542 vol |
96,542 | |
| Filed 2020-01-13 22:29 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Indirect Ownership)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:29 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$411,910
+128,722 vol $3.20 each |
1,833,066 | |
| Filed 2020-01-13 22:23 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+609 vol |
609 | |
| Filed 2020-01-13 22:21 Tx date 2013-07-14 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:21 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+914 vol |
914 | |
| Filed 2020-01-13 22:18 Tx date 2013-07-14 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-13 22:18 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,001
+1,218 vol $4.11 each |
1,218 | |
| Filed 2020-01-13 22:16 Tx date 2013-07-14 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Holder: Kathi Niffenegger Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-09-13 16:27 Tx date 2019-09-11 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,345.1283
-1,809 vol $5.72 each |
6,165 | |
| Filed 2019-09-13 16:25 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-39,950 vol |
7,974 | |
| Filed 2019-06-25 09:57 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-39,937 vol |
||
| Filed 2019-06-10 20:29 Tx date 2019-06-10 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-39,937 vol |
||
| Filed 2019-07-31 15:51 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+8,600 vol |
157,599 | |
| Filed 2019-07-31 15:51 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+93,006 vol |
1,704,344 | |
| Filed 2019-07-31 14:06 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+786 vol |
14,369 | |
| Filed 2019-07-31 14:04 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+8,600 vol |
157,599 | |
| Filed 2019-07-31 14:04 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+93,006 vol |
1,704,344 | |
| Filed 2019-07-31 14:01 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Pay, Paul William
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
11 - Acquisition or disposition carried out privately
|
$3,931
+1,820 vol $2.16 each |
32,399 | |
| Filed 2019-07-31 13:58 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The Digestive Health Clinic Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+12,588 vol |
224,094 | |
| Filed 2019-07-31 13:57 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
11 - Acquisition or disposition carried out privately
|
$196.56
+91 vol $2.16 each |
72,044 | |
| Filed 2019-07-31 13:56 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
11 - Acquisition or disposition carried out privately
|
$5,760
+2,667 vol $2.16 each |
71,953 | |
| Filed 2019-07-31 13:54 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+118,345 vol |
2,106,769 | |
| Filed 2019-07-31 13:53 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+30,183 vol |
537,312 | |
| Filed 2019-07-31 13:50 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
11 - Acquisition or disposition carried out privately
|
$196.56
+91 vol $2.16 each |
162,335 | |
| Filed 2019-07-31 13:48 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
11 - Acquisition or disposition carried out privately
|
$2,948
+1,365 vol $2.16 each |
162,244 | |
| Filed 2019-07-31 13:46 Tx date 2019-07-26 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
11 - Acquisition or disposition carried out privately
|
$16,552
+7,663 vol $2.16 each |
160,879 | |
| Filed 2019-06-27 09:14 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-67,917 vol |
13,583 | |
| Filed 2019-06-27 09:13 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
MacDonald, Sean A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
81,500 | ||
| Filed 2019-06-27 09:09 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-766,083 vol |
153,216 | |
| Filed 2019-06-27 09:08 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Brooks, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
919,299 | ||
| Filed 2019-06-25 10:12 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-25 10:12 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-25 10:12 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-25 10:04 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-25 10:03 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-25 10:03 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Johnson, Lorin Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-25 09:57 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-4,762 vol |
952 | |
| Filed 2019-06-25 09:57 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-39,937 vol |
7,987 | |
| Filed 2019-06-25 09:55 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-11,549 vol |
2,310 | |
| Filed 2019-06-11 19:58 Tx date 2019-06-10 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-4,762 vol |
||
| Filed 2019-06-10 20:29 Tx date 2019-06-10 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Oakes, Frank R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-39,937 vol |
||
| Filed 2019-06-10 20:26 Tx date 2019-06-10 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Niffenegger, Kathi
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-11,549 vol |
||
| Filed 2019-06-20 17:36 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-744,992 vol |
148,999 | |
| Filed 2019-06-20 17:32 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-8,056,689 vol |
1,611,338 | |
| Filed 2019-06-20 17:31 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
893,991 | ||
| Filed 2019-06-20 17:30 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,668,027 | ||
| Filed 2019-06-20 17:28 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-744,992 vol |
148,999 | |
| Filed 2019-06-20 17:27 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-8,056,689 vol |
1,611,338 | |
| Filed 2019-06-20 17:26 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II (International), L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
893,991 | ||
| Filed 2019-06-20 17:25 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Lumira Capital Investment Management Inc.
3 - 10% Security Holder of Issuer
Holder: Lumira Capital II, LP. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,668,027 |